MedPlast, Inc., the innovative technology and process leader in manufacturing support for Healthcare and Industrial specialty markets, announced the completion of its structural alignment with United Plastics Group, Inc. (UPG), according to Harold Faig, CEO of MedPlast.
As a result, said Faig, today's MedPlast is "a dynamic synthesis of two powerful and distinct brands, each aligned with its customers for optimal efficiency and service."
UPG, acquired earlier this year, is a world-class, full-service manufacturer of precision plastic products and value-added services that now focuses on four key industrial specialty markets: Datacenter, Consumer, Automotive and Energy, for optimal alignment with the MedPlast brand's core competencies in healthcare.
"We remain committed to excellence, and continue to cultivate the strengths of each individual entity," Faig said. "It is an approach that allows customers to capitalize on our unique industry synergies and solutions that deliver superior return on investment."
"Each brand retains its focus, delivers industry-leading solutions to its individual customer base, and allows for growth from new business and organically," he said. "A recent example of how our strategy works to the benefit of all parties is the major on-shoring business win of the UPG Minneapolis plant."
The announcement comes on the official opening of the UPG brand 36,000-square foot Houston facility, with 15 molding presses that, in addition to injection molding, delivers automated assembly, pad printing, sonic welding, custom fixture manufacturing and more.
Importantly for customers, UPG shares core values with MedPlast, said Faig. "This customer-first orientation, combined with the ongoing creation of state-of-the-art facilities worldwide, has enhanced our ability to provide multiple options for meeting the most difficult customer requirements, no matter what the technical imperative or supply chain challenge," Faig said.
THE NEW ALIGNMENT: A SUMMARY
With the completion of its structural alignment, the combination of MedPlast and UPG represents, in total, 14 manufacturing locations worldwide.
UPG's former healthcare plants now operate under the MedPlast aegis. Today, the UPG brand operates two plants in China, one in Wales, and two in the U.S. The primary focus is on specialty Industrial markets, as noted earlier.
The MedPlast brand today includes nine facilities, which concentrate on the healthcare market. In addition to the original five U.S.-based MedPlast operations, these include UPG's former dedicated Healthcare facility and tooling operation in China, another in Mexico and two in the U.S.
ABOUT MEDPLAST AND UPG
MedPlast's expertise includes injection molding, liquid injection molding (LIM), two-shot molding, over molding, insert molding, multi-component molding, extrusion, blow molding, injection blow molding, injection stretch blow molding, silicone extrusion, compression and transfer molding, and precision mold making.
In addition, MedPlast offers complete solutions for processing elastomeric and silicone materials, as well as value-added capabilities such as partial- and full-assembly, contract sterilization, lab services as well as global supply chain and logistics management. With state of the art facilities in China, including precision mold making, MedPlast provides worldwide project management.
UPG is a full-service solutions provider with an expanding customer base focused upon industrial specialty markets. As a result of this new orientation, the brand has dramatically increased plant utilization and heightened its ability to win major on-shoring assignments.
The UPG brand is poised to provide greater choice for its customers and deliver superior return on investment through its unified quality system and global supply chain and logistics management across three continents, in multiple facilities.